Clinical Trial Update: Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension [Phase 4]

View source ↗

Summary

Phase 4 study examining the pharmacokinetic effects, blood pressure, and heart rate of Adalat LA (nifedipine) and Coracten in fed patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Adalat LA (nifedipine)
• Coracten

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 4 | Status: COMPLETED